Page last updated: 2024-08-24

gemcitabine and plastochromanol 8

gemcitabine has been researched along with plastochromanol 8 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aggarwal, BB; Deorukhkar, A; Dey, S; Diagaradjane, P; Gelovani, JG; Guha, S; Koca, C; Krishnan, S; Kunnumakkara, AB; Ravindran, J; Sung, B; Tong, Z; Yadav, VR1
Abu-Fayyad, A; Nazzal, S1

Other Studies

2 other study(ies) available for gemcitabine and plastochromanol 8

ArticleYear
{Gamma}-tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironment.
    Cancer research, 2010, Nov-01, Volume: 70, Issue:21

    Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Blotting, Western; Cell Proliferation; Chromans; Cyclooxygenase 2; Deoxycytidine; Drug Resistance, Neoplasm; Gemcitabine; Humans; Inflammation; Inflammation Mediators; Male; Matrix Metalloproteinase 9; Mice; Mice, Nude; NF-kappa B; Pancreatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Ribonucleotide Reductases; RNA, Messenger; Tumor Cells, Cultured; Vitamin E; Xenograft Model Antitumor Assays

2010
Gemcitabine-vitamin E conjugates: Synthesis, characterization, entrapment into nanoemulsions, and in-vitro deamination and antitumor activity.
    International journal of pharmaceutics, 2017, Aug-07, Volume: 528, Issue:1-2

    Topics: Antineoplastic Agents; Cell Line, Tumor; Chromans; Deamination; Deoxycytidine; Gemcitabine; Humans; Nanoparticles; Tocotrienols; Vitamin E

2017